Production Featured Articles

31. Advanced Process Development And Manufacturing Solutions 6/11/2026

    Scaling complex chemical processes requires early risk identification, integrated safety and analytical expertise, and efficient tech transfer.

32. Don't Let Your Filling Equipment Dictate Your Drug Formulation 6/1/2026

    Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.

33. Small Joint Implants: A New Era With Medureon™ Bionate 5/27/2026

    Advances in biomaterials address challenges of small joint implants, improving durability, flexibility, and biocompatibility to reduce wear, enhance motion, and support long‑term patient outcomes.

34. Keeping mAb Aggregation Low During The Final UF/DF Step 5/22/2026

    mAb aggregation can arise from molecular properties, process conditions, and equipment‑driven stress. Learn where aggregation risk increases across downstream processing and formulation.

35. Simulating PUPSIT Or Gas Purges In Bacterial Challenge Tests 5/22/2026

    Managing PUPSIT‑related risks is a critical part of contamination control. Learn how bacterial retention studies, wetting fluids, and downstream practices influence sterility assurance.

36. Product-Wet Integrity Testing: Risk-Based Strategies 5/22/2026

    When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.

37. How Tech Can Drive In-House API Manufacturing 5/20/2026

    Pharmaceutical companies are increasingly moving API production in-house, taking advantage of advanced manufacturing technologies (AMTs) like continuous flow chemistry and automation to drive efficiency, though high costs and cultural shifts remain challenges. By investing in specialized training and strategic facility upgrades, manufacturers can leverage these tools to mitigate supply chain risks, enhance quality, reduce operational complexity, and gain greater control over production timelines.

38. Highly Potent Active Pharmaceutical Ingredients 5/19/2026

    Empower safer, faster development of complex therapeutics by partnering with an HPAPI‑focused CDMO that delivers proven containment, rigorous quality, and end‑to‑end expertis

39. In Vivo Manufacturing: When The Body Becomes The Bioreactor 5/15/2026

    Breakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.

40. Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design 5/6/2026

    Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.